Elanco | Rising to the Top of the Pecking Order

Formerly part of Eli Lilly and Company, Elanco (NYSE: ELAN) has evolved into a global pharmaceutical leader with a comprehensive portfolio of products and services aimed at preventing and treating diseases in pets and livestock. In 2022, Elanco issued an RFP seeking an agency partner to help elevate its presence in the highly competitive poultry sector. As an ACD/Copywriter at Dalton Agency, I collaborated on a spec creative proposal that successfully secured the account. From there, I crafted a bold, irreverent campaign for Elanco Poultry—a fresh approach designed to cut through the noise in a crowded, often conservative market.

Previous
Previous

New York Life Investments

Next
Next

Zoo Atlanta